Drug Type Small molecule drug |
Synonyms 2-oxopropanoic acid ethyl ester, 2-oxopropionic acid ethyl ester, Ethyl 2-oxopropanoate + [6] |
Target |
Action inhibitors |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC5H8O3 |
InChIKeyXXRCUYVCPSWGCC-UHFFFAOYSA-N |
CAS Registry617-35-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronary Disease | Phase 2 | United States | 01 Apr 2005 | |
Heart Valve Diseases | Phase 2 | United States | 01 Apr 2005 | |
Shock | Phase 2 | United States | - | |
Systemic Inflammatory Response Syndrome | Phase 2 | - | - |